(Q35549459)

English

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors

scientific article published on 23 March 2011

Statements

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors (English)
Christopher A Slapak

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit